CV Sciences, Inc. Applauds Governor Abbot's Veto of Senate Bill 3
CV Sciences (OTCQB:CVSI), a consumer wellness company focused on hemp extracts, commends Texas Governor Greg Abbott's decision to veto Senate Bill 3. The bill would have effectively banned the sale of consumable hemp products in Texas.
The vetoed legislation posed a significant threat to Texas's hemp industry, which provides employment to thousands and supplies wellness products statewide. Governor Abbott emphasized the need for a regulatory framework that ensures public safety, aligns with federal law, maintains proper enforcement funding, and can be implemented without delays.
CV Sciences (OTCQB:CVSI), un'azienda nel settore del benessere dei consumatori focalizzata sugli estratti di canapa, apprezza la decisione del governatore del Texas Greg Abbott di veto al Senate Bill 3. Il disegno di legge avrebbe di fatto vietato la vendita di prodotti commestibili a base di canapa in Texas.
La legislazione bloccata rappresentava una minaccia significativa per l'industria della canapa texana, che dà lavoro a migliaia di persone e fornisce prodotti per il benessere in tutto lo stato. Il governatore Abbott ha sottolineato la necessità di un quadro normativo che garantisca la sicurezza pubblica, sia in linea con la legge federale, mantenga i fondi adeguati per l'applicazione delle norme e possa essere implementato senza ritardi.
CV Sciences (OTCQB:CVSI), una empresa de bienestar para consumidores centrada en extractos de cáñamo, felicita la decisión del gobernador de Texas, Greg Abbott, de vetar el Senate Bill 3. El proyecto de ley habrÃa prohibido efectivamente la venta de productos comestibles de cáñamo en Texas.
La legislación vetada representaba una amenaza significativa para la industria del cáñamo en Texas, que emplea a miles de personas y suministra productos de bienestar en todo el estado. El gobernador Abbott enfatizó la necesidad de un marco regulatorio que garantice la seguridad pública, esté alineado con la ley federal, mantenga la financiación adecuada para la aplicación y pueda implementarse sin demoras.
CV Sciences (OTCQB:CVSI)ëŠ� 헴프 ì¶”ì¶œë¬¼ì— ì¤‘ì ì� ë‘� 소비ìž� 웰니ìŠ� 회사로서 í…사ìŠ� 주지ì‚� ê·¸ë ‰ ì• ë´‡ì� ìƒì› 법안 3í˜¸ì— ê±°ë¶€ê¶Œì„ í–‰ì‚¬í•� ê²°ì •ì� 환ì˜í•©ë‹ˆë‹�. ì� ë²•ì•ˆì€ í…사스ì—ì„� ì„ì·¨ 가능한 헴프 ì œí’ˆì� íŒë§¤ë¥� 사실ìƒ� 금지í•� 뻔했습니ë‹�.
ê±°ë¶€ë� ë²•ì•ˆì€ ìˆ˜ì²œ ëª…ì˜ ê³ ìš©ì� ì œê³µí•˜ê³ ì£� ì „ì—ì—� 웰니ìŠ� ì œí’ˆì� 공급하는 í…사ìŠ� 헴프 ì‚°ì—…ì—� 심ê°í•� 위협ì� ë˜ì—ˆìŠµë‹ˆë‹�. ì• ë´‡ 주지사는 공공 ì•ˆì „ì� ë³´ìž¥í•˜ê³ ì—°ë°©ë²•ê³¼ ì¼ì¹˜í•˜ë©° ì ì ˆí•� ì§‘í–‰ ìžê¸ˆì� ìœ ì§€í•˜ê³ ì§€ì—� ì—†ì´ ì‹œí–‰í•� ìˆ� 있는 ê·œì œ 체계ì� í•„ìš”ì„±ì„ ê°•ì¡°í–ˆìŠµë‹ˆë‹¤.
CV Sciences (OTCQB:CVSI), une entreprise de bien-être axée sur les extraits de chanvre, félicite la décision du gouverneur du Texas, Greg Abbott, de veto sur le Senate Bill 3. Ce projet de loi aurait effectivement interdit la vente de produits comestibles à base de chanvre au Texas.
La législation rejetée représentait une menace importante pour l'industrie du chanvre au Texas, qui emploie des milliers de personnes et fournit des produits de bien-être à l'échelle de l'État. Le gouverneur Abbott a souligné la nécessité d'un cadre réglementaire garantissant la sécurité publique, conforme à la loi fédérale, assurant un financement adéquat de l'application et pouvant être mis en œuvre sans retard.
CV Sciences (OTCQB:CVSI), ein Verbraucher-Wellness-Unternehmen mit Fokus auf Hanfextrakte, begrüßt die Entscheidung von Texas Gouverneur Greg Abbott, den Senate Bill 3 zu vetieren. Das Gesetz hätte den Verkauf von konsumierbaren Hanfprodukten in Texas effektiv verboten.
Die abgelehnte Gesetzgebung stellte eine erhebliche Bedrohung für die Hanfindustrie in Texas dar, die Tausende beschäftigt und landesweit Wellness-Produkte liefert. Gouverneur Abbott betonte die Notwendigkeit eines regulatorischen Rahmens, der die öffentliche Sicherheit gewährleistet, mit Bundesgesetzen übereinstimmt, eine angemessene Durchsetzungsfinanzierung sicherstellt und ohne Verzögerungen umgesetzt werden kann.
- Veto preserves CV Sciences' ability to continue operations in Texas market
- Protection of existing hemp industry jobs and businesses in Texas
- Maintained access to federally legal hemp products for Texas consumers
- None.
SAN DIEGO, CALIFORNIA / / June 23, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today applauds Texas Governor Greg Abbott for vetoing Senate Bill 3, which would have created an effective ban on the sale of consumable hemp products across the state of Texas.
The proposed legislation posed a direct threat to Texas's robust hemp industry, which supports thousands of jobs and provides effective wellness products for consumers throughout the state. Senate Bill 3 would have effectively removed the majority of hemp-derived products currently available on the market, disrupting small businesses and limiting consumer access to federally legal wellness alternatives. We agree with Governor Abbott as he declared in his veto statement: "Texas must enact a regulatory framework that protects public safety, aligns with federal law, has a fully funded enforcement structure, and can take effect without delay."
CV Sciences remains committed to advocating for science-backed, safe and legal access to hemp-derived products across the country. The Company thanks Governor Abbott for recognizing the consumer impact of this bill.
About CV Sciences, Inc.
CV Sciences, Inc. (OTCQB:CVSI) is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company's hemp extracts and other proven, science-backed, natural ingredients and products are sold through a range of sales channels from B2B to B2C. The Company's +PlusCBD� branded products are sold at select retail locations throughout the U.S. and are the top-selling hemp-extract brand in the natural products market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. With a commitment to science, PlusCBD� product benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov. +PlusCBD� was the first hemp extract supplement brand to invest in the scientific evidence necessary to receive self-affirmed Generally Recognized as Safe (GRAS) status. The Company also produces cannabinoid-free supplements under its +PlusHLTH� brand, with targeted formulations to optimize health, improve performance, and increase vitality. Our Cultured Foods� brand provides a variety of
Forward Looking Statements
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risk and uncertainties. CV Sciences does not undertake any obligation to publicly update any forward-looking statements, except as required by applicable law. As a result, investors should not place undue reliance on such forward-looking statements.
Contact Information
SOURCE: CV Sciences, Inc.
View the original on ACCESS Newswire